About: Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review
Creator	Zhen, Yuhong Li, Xiaoyu Wang, Lili Xu, Yongping Li, Shuying
Source	Medline; PMC
abstract	In recent years, the use of in-feed antibiotics for growth and disease prevention in livestock production has been under severe scrutiny. The use and misuse of in-feed antibiotics has led to problems with drug residues in animal products and increased bacterial resistance. Chicken egg yolk antibodies (IgY) have attracted considerable attention as an alternative to antibiotics to maintain swine health and performance. Oral administration of IgY possesses many advantages over mammalian IgG such as cost-effectiveness, convenience and high yield. This review presents an overview of the potential to use IgY immunotherapy for the prevention and treatment of swine diarrhea diseases and speculates on the future of IgY technology. Included are a review of the potential applications of IgY in the control of enteric infections of either bacterial or viral origin such as enterotoxigenic Escherichia coli, Salmonella spp., rotavirus, porcine transmissible gastroenteritis virus, and porcine epidemic diarrhea virus. Some potential obstacles to the adoption of IgY technology are also discussed.
has issue date	2015-08-25(xsd:dateTime)
bibo:doi	10.1186/s40104-015-0038-8
bibo:pmid	26309735
has license	cc-by
sha1sum (hex)	1d720a06cad9b69f7f45a4e7549142738114287e
schema:url	https://doi.org/10.1186/s40104-015-0038-8
resource representing a document's title	Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review
has PubMed Central identifier	PMC4549021
has PubMed identifier	26309735
schema:publication	J Anim Sci Biotechnol
resource representing a document's body	covid:1d720a06cad9b69f7f45a4e7549142738114287e#body_text
is schema:about of	named entity 'swine' named entity 'origin' named entity 'swine' named entity 'RECENT' named entity 'IGY' named entity 'EGG YOLK' named entity 'YEARS' named entity 'GROWTH' named entity 'REVIEW' named entity 'PRODUCTION' named entity 'HIGH YIELD' covid:arg/1d720a06cad9b69f7f45a4e7549142738114287e named entity 'HAVE' named entity 'LED' named entity 'OVERVIEW' named entity 'FEED' named entity 'ANTIBODIES' named entity 'ENHANCERS' named entity 'USE' named entity 'APPLICATIONS' named entity 'IGG' named entity 'POTENTIAL' named entity 'TO MAINTAIN' named entity 'CONTROL' named entity 'NON-' named entity 'CHICKEN EGG' named entity 'SWINE' named entity 'EGG YOLK' named entity 'ANTIBODIES' named entity 'ATTENTION' named entity 'FUTURE' named entity 'PERFORMANCE' named entity 'DISEASE PREVENTION' named entity 'ENTERIC' named entity 'DISEASES' named entity 'CHICKEN EGG' named entity 'SCRUTINY' named entity 'DIARRHEA' named entity 'CONSIDERABLE' named entity 'DRUG RESIDUES' named entity 'INFECTIONS' named entity 'LIVESTOCK PRODUCTION' named entity 'INCREASED' named entity 'ROTAVIRUS' named entity 'ORIGIN' named entity 'ENTEROTOXIGENIC ESCHERICHIA COLI' named entity 'PRESENTS' named entity 'BACTERIAL RESISTANCE' named entity 'TECHNOLOGY' named entity 'REVIEW OF' named entity 'MAMMALIAN' named entity 'PREVENTION' named entity 'ALTERNATIVE' named entity 'COST-EFFECTIVENESS' named entity 'TREATMENT' named entity 'PORCINE EPIDEMIC DIARRHEA VIRUS' named entity 'CONVENIENCE' named entity 'SEVERE' named entity 'HEALTH' named entity 'ADOPTION' named entity 'VIRAL' named entity 'ANIMAL PRODUCTS' named entity 'BACTERIAL' named entity 'USE' named entity 'SWINE' named entity 'PROBLEMS' named entity 'INCLUDED' named entity 'ANTIBIOTIC' named entity 'MISUSE' named entity 'IMMUNOTHERAPY' named entity 'SALMONELLA SPP.' named entity 'ANTIBIOTICS' named entity 'ORAL ADMINISTRATION' named entity 'USE OF' named entity 'POSSESSES' named entity 'EITHER' named entity 'PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software